Hong-Chuang Xu

Conformational adjustment overcomes multiple drug-resistance mutants of tropomyosin receptor kinase.

Wei Huang, Guang-Fu Yang, Long-Can Mei, 2022, European journal of medicinal chemistry.

Discovery of 3-pyrazolyl-substituted pyrazolo[1,5-a]pyrimidine derivatives as potent TRK inhibitors to overcome clinically acquired resistance.

Wei Huang, Guang-Fu Yang, Feng-Xu Wu, 2022, European journal of medicinal chemistry.

Efficient Arylation of 2,7-Naphthyridin-1(2H)-one with Diaryliodonium Salts and Discovery of New Selective MET/AXL Kinase Inhibitor.

Wei Huang, Ming-Shu Wang, Ren-Yu Qu, 2020, ACS combinatorial science.

Structure-activity relationship study of novel quinazoline-based 1,6-naphthyridinones as MET inhibitors with potent antitumor efficacy.

Wei Huang, Xiao-Lei Zhu, Ming-Shu Wang, 2020, European journal of medicinal chemistry.

Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2.

Wei Huang, Nengfang She, Feng-Xu Wu, 2020, Bioorganic & medicinal chemistry.

2,7-naphthyridinone-based MET kinase inhibitors: A promising novel scaffold for antitumor drug development.

Wei Huang, Guang-Fu Yang, Xiao-Lei Zhu, 2019, European journal of medicinal chemistry.

Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology

Wei Huang, Guang-Fu Yang, Ming-Shu Wang, 2021, Topics in Current Chemistry.

Discovery of Next-Generation Tropomyosin Receptor Kinase Inhibitors for Combating Multiple Resistance Associated with Protein Mutation.

Wei Huang, Guang-Fu Yang, Ming-Shu Wang, 2021, Journal of medicinal chemistry.